AUG 04, 2020 2:23 PM PDT

Commonly used pesticides, approved by EPA, linked to mammary gland tumors

In an analysis of how regulators review pesticides for their potential to cause cancer, researchers at Silent Spring Institute identified more than two dozen registered pesticides that were linked with mammary gland tumors in animal studies. The new findings raise concerns about how the US Environmental Protection Agency (EPA) approves pesticides for use and the role of certain pesticides in the development of breast cancer.

Photo: Pixabay

New research from scientists at Silent Spring Institute publishes an extensive list of registered pesticides (approved by the US Environmental Protection Agency) that is demonstrated to be linked to mammary gland tumors in animal studies. The toxicology report highlight the need for more informed regulation on pesticides that are supposedly “safe”.

Reported in the journal Molecular and Cellular Endocrinology, the investigation began when Silent Spring scientists found that exposure to a common herbicide called triclopyr caused rodents to develop mammary gland tumors.

Ruthann Rudel, an environmental toxicologist and director of research at Silent Spring, commented that this initial finding sparked suspicion. "We know pesticides like DDT increase breast cancer risk, so we decided to look into it," says co-author Rudel. "After examining pesticide registration documents from EPA, we found two separate studies in which rodents developed mammary gland tumors after being exposed to triclopyr, yet for some reason regulators dismissed the information in their decision not to treat it as a carcinogen." Was the same oversight happening with other pesticides?

Rudel and colleague scientist Bethsaida Cardona reviewed more than 400 EPA pesticide documents in order to categorize the health effects of each pesticide. In their analysis, they identified 28 pesticides that are linked with mammary gland tumors. Only nine were flagged by the EPA.

Of the 28 registered pesticides identified with a link to mammary gland tumors, many are endocrine disruptors, meaning they alter steroid synthesis in H295R cells, activate nuclear receptors, or affect xenobiotic-metabolizing enzymes.

The team urges the EPA to re-evaluate five key pesticides that are widely used: malathion, triclopyr, atrazine, propylene oxide, and 3-iodo-2-propynyl butylcarbamate (IPBC). As Eureka Alert reports, “IPBC is a preservative in cosmetics; triclopyr is an agricultural herbicide that is also used to control vegetation growth along rights-of-way; malathion is a common residential and agricultural pesticide and is used in some lice treatments; atrazine is one of the most commonly used herbicides in agriculture; and propylene oxide is used to preserve food, cosmetics, and pharmaceuticals, and has many similarities with ethylene oxide, a known human carcinogen.”

"In light of our findings, we hope EPA updates its guidelines for assessing mammary gland tumors by considering evidence that more completely captures the biology of breast cancer, such as the effects of endocrine disruptors," says Cardona.

Sources: Molecular and Cellular Endocrinology, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
MAY 28, 2021
Cancer
Does your birth control increase your risk of breast cancer?
MAY 28, 2021
Does your birth control increase your risk of breast cancer?
A study published recently in EMBO Molecular Medicine considers the biological impacts of progestins from hormonal contr ...
JUN 10, 2021
Cell & Molecular Biology
Does Lithium Prevent Colon Cancer?
JUN 10, 2021
Does Lithium Prevent Colon Cancer?
Researchers found that a drug used in the treatment of mental illness can promote the fitness of healthy gut stem cells, ...
JUN 07, 2021
Cancer
Inflammatory-rich diet associated with greater risk of developing breast cancer
JUN 07, 2021
Inflammatory-rich diet associated with greater risk of developing breast cancer
A breakthrough study soon to be presented at NUTRITION 2021 LIVE ONLINE later this week reports that women who main ...
JUN 06, 2021
Cancer
New drug reduces tumor size in lung cancer patients with KRAS gene mutation
JUN 06, 2021
New drug reduces tumor size in lung cancer patients with KRAS gene mutation
The most recent results from the CODEBREAK 100 phase 2 clinical trial support the use of the drug sotorasib to reduce tu ...
JUN 09, 2021
Technology
Computer Program Generates Effective, Clinically-valid Treatment Plans for Cancer Patients
JUN 09, 2021
Computer Program Generates Effective, Clinically-valid Treatment Plans for Cancer Patients
In a recent study published in Nature Medicine, researchers at the Princess Margaret Cancer Centre offer evidence for th ...
SEP 23, 2021
Drug Discovery & Development
The FDA approves the first and only oral treatment for a certain non-small cell lung cancer.
SEP 23, 2021
The FDA approves the first and only oral treatment for a certain non-small cell lung cancer.
Last week, the United States Food and Drug Administration (FDA) granted approval for the first oral therapy to ...
Loading Comments...